About LightLab Imaging

LightLab Imaging

LightLab Imaging.  Cardiology & Endoscopy Systems.  LightLab Imaging is focused on developing Optical Coherence Tomography (OCT). OCT is a new high-resolution high-speed imaging modality that uses advanced photonics for imaging and tissue characterization. Our mission is to help physicians make earlier and more accurate diagnosis of a wide range of diseases including heart disease and cancer.  OCT has been the subject of intensive, worldwide research efforts and is featured prominently at international scientific and medical conferences.

Read More

LightLab has developed a strong portfolio of fundamental OCT patents.  LightLab employees include pioneers in the development and application of OCT from MIT, Harvard, Lincoln Laboratory and Carl Zeiss, Inc. Company executives and staff also contribute a strong knowledge of heath care and medical device development with significant experience in device development, manufacturing and marketing with companies such as Hewlett-Packard, Agilent Technologies, Boston Scientific and C.R. Bard.  LightLab Imaging has a strong intellectual property position with technology acquired from MIT, Harvard University, Massachusetts General Hospital, Tufts University, Medtronic, and the Zeiss Foundation, as well as numerous internally developed patents.  On July 31st 2002, LightLab Imaging became a subsidiary of Goodman Co. Ltd., a Japanese corporation which has a built a long track record of success in interventional cardiology. 

  1. Mentioned In 237 Articles

  2. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial

    Explore Article Heart (Aug 24 2010)

    Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial Background A potentially adverse vascular response to overlapping drug eluting stents (DES) has been suggested in current research. Objective To evaluate the impact of baseline disease severity at the site of stent overlap. Methods and results This is a substudy of ODESSA, a prospective, randomised controlled trial designed to evaluate healing of overlapping stents. 71/77 patients with a total of 86 overlapping stents were studied: 25 sirolimus, 24 paclitaxel, 26 ... (Read Full Article)

    Comment on Article Mentions:   Case Western Reserve University   National Institutes of Health   LightLab Imaging

  3. 2010 Prism Awards: showcase your products -The deadline for entries to this year's Prism Awards is fast approaching: make sure you apply by September 17.

    Explore Article optics.org (Aug 23 2010)

    2010 Prism Awards: showcase your products -The deadline for entries to this year's Prism Awards is fast approaching: make sure you apply by September 17. The deadline for entries to this year's Prism Awards is fast approaching: make sure you apply by September 17. If your company has developed a photonic product that breaks with convention, solves a problem or improves life in general - why not tell the world all about it by entering the 2010 Prism Awards? Sponsored by SPIE in collaboration with Photonics Media, these "Oscars" for the photonics industry are eligible ... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   St. Jude Medical

  4. 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side Branches by Bioresorbable Vascular Scaffolds: A Proposal for Classification

    Explore Article interventions.onlinejacc.org (Aug 16 2010)

    3-Dimensional Optical Coherence Tomography Assessment of Jailed Side Branches by Bioresorbable Vascular Scaffolds: A Proposal for Classification ... trial to assess the safety and performance of the BVS. Fourier-domain OCT pullbacks (C7-XR system, LightLab Imaging Inc., Westford, Massachusetts) are obtained at pullback speed of 20 mm/s and 3D renderings are perf... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Patrick W. Serruys   Evelyn Regar

  5. iPad, iPhone app to teach St. Jude docs about intravascular OCT

    Explore Article MedCity News (Aug 11 2010)

    iPad, iPhone app to teach St. Jude docs about intravascular OCT ...the Web will teach St. Jude doctors and radiologists how to use the intravascular OCT technology of LightLab Imaging Inc., the Westford, Massachusetts, company recently acquired by St. Jude. LightLab’s C7-XR Imaging System and accompanying C7 Dragonfly Imaging Catheter (pdf) use light to produce im... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Marco A. Costa   Lightlab C7 XR OCT Imaging System

  6. Severe Coronary Spasm Induced by OCT Wire. There Are No Innocuous Procedures

    Explore Article Invasive Cardiology (Aug 6 2010)

    Severe Coronary Spasm Induced by OCT Wire. There Are No Innocuous Procedures ...as proposed and performed using the Imagewire imaging catheter and the M2x Coronary Imaging System (LightLab Imaging, Westford, Massachusetts). The initial evaluation revealed a luminal area of 6 cm2 (Figure 1B) at t... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Hospital Universitario La Paz   Santiago Jiménez-Valero

  7. Volcano Corporation Estimates Regulatory Approval for its OCT Cardiology System in 2011 but Potential Engineering, Regulatory, and Legal Issues Remain

    Explore Article Optical Coherence Tomography News (Jul 31 2010)

    Volcano Corporation Estimates Regulatory Approval for its OCT Cardiology System in 2011 but Potential Engineering, Regulatory, and Legal Issues Remain ...n July 27, 2010 St. Jude (STJ, Market Cap ~$12B, Earnings ~$1B), which completed its acquisition of Lightlab Imaging on July 6th, 2010 shortly after LightLab received FDA approval for its cardiovascular product, also filed another suit on a patent infringem... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Axsun Technologies   Daniel J. Starks

  8. St. Jude, Volcano battle in court over FFR technology

    Explore Article Cardiovascularbusiness.com (Jul 28 2010)

    St. Jude, Volcano battle in court over FFR technology ...nesday, July 28 2010 FURTHER READING Portal * Cardiovascular Imaging Company * Axsun Technologies * LightLab Imaging * Radi Medical Systems * St. Jude Medical * Volcano Organization * Superior Court of Massachusetts,... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Axsun Technologies   St. Jude Medical

  9. Medical Device Battle: Can St. Jude Bigfoot Volcano? (CNBC Video)

    Explore Article cnbc.com (Jul 28 2010)

    Medical Device Battle: Can St. Jude Bigfoot Volcano? (CNBC Video) This is one of those corporate battles that sometimes falls through the reporting cracks, but shouldn't. In one corner we have St. Jude Medical, the big medical device company. In the other: Volcano Corporation, which has been rapidly growing with several specialty products. Volcano's biggest product is intravascular ultrasound, which is used to help in the placement of heart stents. It's also big in something called fractional flow reserve, or ... (Read Full Article)

    Comment on Article Mentions:   St. Jude Medical   Volcano   LightLab Imaging

  10. St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S.

    Explore Article Optical Coherence Tomography News (Jul 28 2010)

    St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S. ...treatment. The patent lawsuit initiated today follows St. Jude Medical’s recent acquisition of LightLab Imaging, Inc., which is already engaged in litigation against Volcano and its wholly owned subsidiary Axsun...... litigation against Volcano and its wholly owned subsidiary Axsun Technologies, Inc., a supplier to LightLab. LightLab is a pioneer and leader in the development of Optical Coherence Tomography (OCT) used in coronary i... (Read Full Article)

    Comment on Article Mentions:   Volcano   St. Jude Medical   LightLab Imaging

  11. Volcano Will Strongly Defend Against St. Jude Lawsuit

    Explore Article PR Newswire (Jul 27 2010)

    Volcano Will Strongly Defend Against St. Jude Lawsuit SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) stated today that it will vigorously defend against the patent infringement lawsuit filed against it by St. Jude Medical in federal district court in Delaware. Volcano believes that the claims against it are entirely without merit, and looks forward to vindicating its rights in court. The Complaint filed today has nothing to do with other litigation between the parties, including ... (Read Full Article)

    Comment on Article Mentions:   Axsun Technologies   St. Jude Medical   Volcano

  12. St. Jude Medical alleges patent infringement, stolen trade secrets

    Explore Article massdevice.com (Jul 27 2010)

    St. Jude Medical alleges patent infringement, stolen trade secrets St. Jude Medical Inc. files a patent infringement lawsuit against Volcano Corp. over cardiac guidewires and accuses a former group president of pilfering trade secrets in his move to crosstown rival Medtronic Inc. St. Jude Medical Inc. (NYSE: STJ) filed a pair of lawsuits accusing two of its rivals of patent infringement and stealing trade secrets. The Little Canada, Minn.-based medical device maker filed a lawsuit against Volcano Corp. (NSDQ:VOLC) ... (Read Full Article)

    Comment on Article Mentions:   St. Jude Medical   LightLab Imaging   Volcano

  13. St. Jude posts double-digit gains in sales, income for Q2

    Explore Article CMIO.net (Jul 25 2010)

    St. Jude posts double-digit gains in sales, income for Q2 ...Written by Editorial Staff July 25, 2010 Print Email FURTHER READING Company * Boston Scientific * LightLab Imaging * St. Jude Medical Person * Daniel J. Starks Topic * atrial fibrillation * cardiac rhythm managemen... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Boston Scientific   Daniel J. Starks

  14. St. Jude Medical CEO: second quarter was “absolutely awesome”

    Explore Article MedCity News (Jul 22 2010)

    St. Jude Medical CEO: second quarter was “absolutely awesome” ...estimate includes negative currency impacts and dilution from its recent $90 million acquisition of LightLab Imaging Inc., two factors that shaved about four cents a share. More impressively, STJ’s cardiac rhythm man... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Boston Scientific   St. Jude Medical

  15. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study

    Explore Article Heart (Jul 16 2010)

    Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study Aims To study in-stent tissue characteristics by optical coherence tomography (OCT) at long-term follow-up in patients with previous bare metal stent implantation. Methods and results Among 1636 patients who underwent bare metal stent (BMS) implantation between 1999 and 2006, 39 patients with 60 BMS who developed recurrent ischaemia underwent repeat catheterisation and OCT imaging between June 2008 and August 2009. The average time interval between initial BMS implantation and OCT ... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Massachusetts General Hospital   Ik-Kyung Jang

  16. St. Jude Medical Completes Acquisition of LightLab Imaging

    Explore Article businesswire.com (Jul 6 2010)

    St. Jude Medical Completes Acquisition of LightLab Imaging ...NYSE:STJ), a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash. LightLab is the pioneer and leader in the development of Optical Coherence Tomography (OCT), a high resoluti... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   David W. Kolstad   Craig Kelley

1-15 of 237 // 1 2 3 4 ... 14 15 16 »